Harshal Khanwalkar
Inserm(FR)Institut de génétique et de biologie moléculaire et cellulaire(FR)Université de Strasbourg(FR)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cell death mechanisms and regulation, Retinoids in leukemia and cellular processes, Estrogen and related hormone effects, interferon and immune responses
Most-Cited Works
- → Retinoid receptor subtype-selective modulators through synthetic modifications of RARγ agonists(2009)56 cited
- → Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008(2011)53 cited
- → Modulating Retinoid X Receptor with a Series of (E)-3-[4-Hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic Acids and Their 4-Alkoxy Isomers(2009)46 cited
- → Potentiation of in vitro and in vivoantitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells(2013)40 cited
- → Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers(2012)40 cited
- → Growth Factor-Antagonized Rexinoid Apoptosis Involves Permissive PPARγ/RXR Heterodimers to Activate the Intrinsic Death Pathway by NO(2009)36 cited